Research with Harvard
Carefully crafted by experts with 20+ years experience in child development.
CLINICAL TRIAL: A Serious Game–Derived Index for Detecting Children With Heterogeneous Developmental Disabilities: Randomized Controlled Trial
Study of the Possibility of Detecting Pediatric Mild Developmental Delay through a Serious Game
A Study of the Possibility of Detecting Pediatric Mild Developmental Delay Through a Serious Game: A Randomized Cluster Trial in Cambodia
Some of Our Partners
Evelyn, Age 5
“Evelyn never learned arithmetics, so you can imagine how surprised I was when she started counting by herself. Absolutely amazing!”
Mia, Age 6
"Mia remembers better. She now can tell me the difference between one shape and another. I wish DoBrain would make more programs for older kids."
Si, Age 5
"Stick figures were the only things Si was able to draw. After DoBrain, his drawing has more colors and emotion."
Mateo, Age 5
"My child went from a TV-holic to a DoBrain maniac. He not only remembers colors, but even the back of rotated shapes!”
Denise, Age 3
"At first Denise didn't like getting things wrong. But a couple weeks later, my 3-year-old old autistic child began differentiating shapes and sizes.”
Joshua, Age 4
"I used to be scared to take my son to cafes, because he would shout and throw tantrums. With DoBrain, he sits quietly anywhere.”
How do I subscribe?
Press the SUBSCRIBE button on the upper right corner of the Home Screen within the DoBrain app to find pricing and subscription information.
Frequently Asked Questions
DoBrain is the only learning program available for 3-7 year olds that has been clinically validated for its effects. We pride ourselves in having carefully curated decades of teaching experience into an app, and we're constantly working to improve self-motivated learning for our little users.
Harvard's Beth Israel Deaconess Medical Center (BIDMC) and Massachusetts General Hospital are carrying out research with DoBrain between 2019-2022 to validate the effects of DoBrain on cognition improvement for children in the US. The intention is to use the results as part of our FDA approval process.
We demand only the highest standard of content for our users, and hope to be FDA approved by 2022. A pre-submission application was filed with the FDA in late 2020. Currently, there is an Emergency Use Authorization by the FDA to offer DoBrain as a medical device due to COVID-19.
DoBrain has been tested with children who have borderline developmental delay due to autism, intellectual disability, ADHD, cerebral palsy, and others with positive results.
Each lesson is about 15 minutes long, and is composed of animated stories with carefully designed problem-solving activities. On average, a student will solve 10~15 problems in one lesson.
The app does not require the parent to be present. For best results, keep an eye out for our reports provided after every 7 sessions and upon completion of each milestone (28 sessions). Don't forget to ask your child what he or she learned with DoBrain every day!